MORGAN TEVLIN: Open Payments
NPI 1538656491 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,224 in 72 payments from 18 companies in 2025. Trend: 2023 $1,709 · 2024 $1,738 · 2025 $3,224
Food & beverage: $1,817Travel & lodging: $1,330Education: $77
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,659 |
| Janssen Biotech, Inc. | 12 | $321 |
| Gilead Sciences, Inc. | 11 | $302 |
| GENZYME CORPORATION | 7 | $181 |
| ABBVIE INC. | 7 | $135 |
| Novo Nordisk Inc | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Celltrion USA Inc. | 5 | $83 |
| Lilly USA, LLC | 4 | $72 |
| Madrigal Pharmaceuticals | 3 | $70 |
Products named: INTERSTIM, TREMFYA, DUPIXENT, Epclusa, ENTYVIO, VEGZELMA, RINVOQ, OMVOH.
Industry payments across CO — which companies pay providers there.
